Upregulation or downregulation of PI3K/AKT/mTOR-related oncogenic lncRNAs contributes to aberrant expression of transcriptional activators or oncoproteins, leading to aberrant regulation of the PI3K/AKT/mTOR pathway in HCC [58]. The gene discussed is MTOR; the disease is hepatocellular carcinoma.